Scientist studies DNA repair; hopes to improve breast cancer treatment

January 16, 2013 by Elizabeth K. Gardner, Purdue University

(Medical Xpress)—A Purdue University scientist is studying the way cells repair damaged DNA in the hopes of making cancer cells more susceptible to treatment and normal tissue better able to withstand it.

The National Institutes of Health recognized Pierre-Alexandre Vidi and his research with a Howard Temin Pathway to Independence Award in Cancer for highly promising postdoctoral research scientists. This is the first time a has received the award while at Purdue. The issued the award to 60 researchers in the United States in 2012.

Vidi uses a 3-D cell culture to reproduce and breast cancers with the architecture they would have within the human body. He then studies how cells' organization and interactions influence the process of DNA repair.

"Our ultimate goal is to improve cancer treatment and the quality of life of cancer patients," Vidi said. "We want to learn how to make cancer cells less able to repair themselves after chemotherapy or . This could reduce treatment doses - and the debilitating side effects of those treatments - the patients must endure."

A better understanding of what influences DNA repair could also lead to strategies to boost DNA repair in normal cells and prevent cancer initiation, he said.

Vidi's findings suggest that influences the organization of the and nuclear processes such as DNA repair. He will use the grant to further investigate the underlying mechanisms and how the organization of normal and influences the flow of information that leads to DNA repair.

Vidi's research approach differs from most other cancer researchers due to the inclusion of healthy in parallel to cancers in his studies. He credits his mentor, Sophie Lelièvre, as a leader of this approach. Lelièvre is an associate professor of basic medical sciences in Purdue's College of Veterinary Medicine and associate director of discovery groups in the Purdue Center for Cancer Research.

"Her laboratory is famous for approaching cancer research by first understanding normal tissue behavior," Vidi said. "Dr. Lelièvre's group also is one of the few in the world able to reproduce the complex organization of cells that line the mammary ducts and create 3-D cell culture models."

Vidi's Pathway to Independence Award comes through the National Cancer Institute at the NIH. The competitive award was created in 2007 and provides five years of support comprising two years of mentored support as a postdoctoral fellow followed by three years of support as an independent researcher. In addition to Lelièvre, Vidi's mentors include Joseph Irudayaraj from Purdue's School of Agricultural and Biological Engineering and Tom Misteli from the National Cancer Institute.

"Pierre's training and the mentors he has sought bridge expertise in cancer biology and in biophysical technologies that are the future of this field," said Lelièvre, who also leads the International and Nutrition Project. "He shows tremendous promise as a scientist and cancer researcher and carries the torch of our laboratory's values."

Explore further: Findings suggest how cancer cells can become resistant to DNA damage-inducing treatments

Related Stories

Findings suggest how cancer cells can become resistant to DNA damage-inducing treatments

October 23, 2011
An international team of scientists led by UC Davis researchers has discovered that DNA repair in cancer cells is not a one-way street as previously believed. Their findings show instead that recombination, an important DNA ...

Targeting PTEN may prevent skin cancer

July 26, 2011
Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in Cancer ...

Breakthrough could make 'smart drugs' effective for many cancer patients

June 27, 2011
(Medical Xpress) -- Newcastle and Harvard University reseachers have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors.

Abnormal DNA maintenance related to cancer

December 10, 2012
DNA, like houses and cars, needs ongoing maintenance. Rays of ultraviolet sunlight, chemical pollutants and normal biochemical processes in the cell can damage it. Cells routinely repair this damage before making proteins ...

Heat helps cancer drugs battle cancer

May 10, 2011
(PhysOrg.com) -- Localized hyperthermia has been used occasionally with cancer drugs for some time, but until now, the reason it helps has been a mystery. In a report in the Proceedings of the National Academy of Sciences, ...

Recommended for you

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.